aMAP Score (Hepatocellular Carcinoma Risk)
aMAP Score (Hepatocellular Carcinoma Risk) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the aMAP Score (Hepatocellular Carcinoma Risk) → Runs in your browser. No signup, no tracking.
What this is
aMAP Score (Hepatocellular Carcinoma Risk) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. aMAP Score (Hepatocellular Carcinoma Risk) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Fan R, Papatheodoridis G, Sun J, et al. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. J Hepatol. 2020;73(6):1368-1378. Read the source ↗
Worked example: aMAP score 62.1 — high HCC risk (> 60).
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.